Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'.

IF 5 2区医学 Q1 CLINICAL NEUROLOGY Cephalalgia Pub Date : 2024-10-01 DOI:10.1177/03331024241293104

Linda Al-Hassany, Deirdre M Boucherie, Emile G M Couturier, Antoinette MaassenVanDenBrink

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

作者对 "澄清性功能障碍作为 CGRP 靶向药物不良反应的发生率和性别特异性 "的回复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cephalalgia 医学-临床神经学

CiteScore

10.10

自引率

6.10%

发文量

108

审稿时长

4-8 weeks

期刊介绍： Cephalalgia contains original peer reviewed papers on all aspects of headache. The journal provides an international forum for original research papers, review articles and short communications. Published monthly on behalf of the International Headache Society, Cephalalgia''s rapid review averages 5 ½ weeks from author submission to first decision.

期刊最新文献

Abnormal electromyographical trigeminal activation through stimulation of the offending artery (Z-L response): An intraoperative tool during microvascular decompression for trigeminal neuralgia. A call for academic pragmatic clinical trials to address open questions in migraine prevention. Outcomes, unmet needs, and challenges in the management of patients who withdraw from anti-CGRP monoclonal antibodies: A prospective cohort study. Internal jugular vein valve incompetence: A key consideration in patients with exercise-induced headache. Stroke due to small-vessel disease and migraine: A case-control study of a young adult with ischemic stroke population.